oa SA Pharmaceutical Journal - New product focus : drug info
Xarelto® - a new oral anticoagulant
Rivaroxaban (Xarelto®) is a new oral anticoagulant that was recently registered in South Africa. It is the first of two new orally administered anticoagulants poised to change anticoagulation practices by offering improvements over the current standard of care, such as fixed oral dosing and no need for routine monitoring.
Article metrics loading...